Synchronous Bilateral Stage 1A Non-Small Cell Carcinoma
Patient was unwilling to undergo a second thoracotomy, and instead chose to receive CyberKnife® treatment of the lesion with concurrent chemotherapy.
CyberKnife’s precise delivery allows the expansion of stereotactic radiosurgery and stereotactic body radiation therapy treatments to indications not possible to treat on any other radiation therapy machine.
Patient was unwilling to undergo a second thoracotomy, and instead chose to receive CyberKnife® treatment of the lesion with concurrent chemotherapy.
The CyberKnife System provided a convenient and minimally invasive treatment option for this patient with recurrent ovarian carcinoma who had failed previous surgery and chemotherapy.
Radiosurgery is a practical alternative for both boost therapy after external beam radiotherapy and salvage therapy in patients with recurrent NPC.
The CyberKnife System can deliver complex treatment plans to multiple lesions while minimizing irradiation to the surrounding healthy tissue, thereby decreasing the risk of complications.
Industry-leading service to support your ongoing success, from speedy install and optimization, to proactive monitoring and unrivalled on-site service, to smart upgrade paths to keep your system at the leading edge.
Learn how Accuray radiation technologies enable clinicians to get patients back to living their lives, faster. Explore coming innovations that unlock entirely new possibilities.
The following pages explore some of the many ways clinicians around the globe use Accuray technologies to deliver unique and effective treatments for a wide range of clinical indications.
Accuray is expanding radiation therapy: our products can deliver it accurately, precisely and effectively, from oncology to neuro-radiosurgery and beyond.